Breaking News Instant updates and real-time market news.

ASND

Ascendis Pharma

$73.52

-0.38 (-0.51%)

07:46
01/28/19
01/28
07:46
01/28/19
07:46

Ascendis shares have upside to $95-$100 on positive data, says JPMorgan

JPMorgan analyst Jessica Fye previewed Ascendis Pharma's Phase III readout for its TransCon GH in late February or early March. Based on the clinical data generated thus far, the analyst continues to see a "high probability of success" heading into the data with upside to the $95-$100 share range for the stock on positive results day one and "potentially substantial further upside thereafter as well." She also sees a "substantial downside case" should the trial fail to hit its non-inferiority endpoint to the $20-$30 per share range. However, Fye says her "positive stance into the data stems from a high degree of conviction in phase III success."

ASND Ascendis Pharma
$73.52

-0.38 (-0.51%)

01/24/19
01/24/19
UPGRADE
Target $90

Outperform
Ascendis Pharma upgraded to Outperform at Leerink ahead of TransCon hGH data
As previously reported, Leerink analyst Joseph Schwartz upgraded Ascendis Pharma to Outperform from Market Perform ahead of TransCon hGH Phase 3 data expected this quarter, which he believes has a high probability of validating the company's platform, which includes TransCon CNP and TransCon PTH in mid-stage clinical development. The analyst also raised his price target on the shares to $90 from $73.
01/24/19
CANT
01/24/19
INITIATION
Target $102
CANT
Overweight
Cantor starts Ascendis Pharma with Overweight, $102 price target
Cantor Fitzgerald analyst Alethia Young last night initiated coverage of Ascendis Pharma with an Overweight rating and $102 price target. The analyst is confident in clinical success of TransCon hGH, which he says "should drive a first leg of upside in 2019." She also thinks that investors will assign more credit to the company's platform, especially TransCon PTH with Phase 2 data expected by the end of 2019. Positive Phase 3 data for heiGHt study could lead to 25%-30% share upside in Q1, Young tells investors in a research note.
01/24/19
LEER
01/24/19
UPGRADE
LEER
Outperform
Ascendis Pharma upgraded to Outperform from Market Perform at Leerink
01/23/19
CANT
01/23/19
INITIATION
Target $102
CANT
Overweight
Ascendis Pharma initiated with an Overweight at Cantor Fitzgerald
Cantor analyst Alethia Young initiated Ascendis Pharma with an Overweight and $102 price target.

TODAY'S FREE FLY STORIES

NEPT

Neptune Wellness

$3.49

0.03 (0.87%)

06:38
10/17/19
10/17
06:38
10/17/19
06:38
Hot Stocks
Neptune Wellness to provide extraction services to farming services operation »

Neptune Wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NSRGY

Nestle

$0.00

(0.00%)

06:38
10/17/19
10/17
06:38
10/17/19
06:38
Hot Stocks
Nestle says portfolio management 'fully on track' »

Nestle notes that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNA

Snap-On

$157.68

-0.64 (-0.40%)

06:37
10/17/19
10/17
06:37
10/17/19
06:37
Hot Stocks
Snap-On sees 2019 CapEx $95M-$105M »

Sees 2019 effective…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NSRGY

Nestle

$0.00

(0.00%)

06:37
10/17/19
10/17
06:37
10/17/19
06:37
Earnings
Nestle backs underlying FY19 EPS in constant currency up vs. last year »

Full-year guidance for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

06:37
10/17/19
10/17
06:37
10/17/19
06:37
Earnings
Nestle reports nine month sales CHF68.367B vs. CHF66.424B last year »

Organic growth reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$17.70

-0.08 (-0.45%)

06:35
10/17/19
10/17
06:35
10/17/19
06:35
Earnings
KeyCorp reports Q3 ex-items EPS 48c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HON

Honeywell

$163.86

0.2 (0.12%)

06:35
10/17/19
10/17
06:35
10/17/19
06:35
Earnings
Honeywell narrows FY19 EPS view to $8.10-$8.15 from $7.95-$8.15, consensus $8.09 »

Narrows FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NSRGY

Nestle

$0.00

(0.00%)

06:34
10/17/19
10/17
06:34
10/17/19
06:34
Hot Stocks
Nestle to distribute CHF20B to shareholders via share buybacks »

Nestle's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$3.07

0.335 (12.27%)

, NSRGY

Nestle

$0.00

(0.00%)

06:34
10/17/19
10/17
06:34
10/17/19
06:34
Hot Stocks
New Age Beverages partners with Nestle to relaunch NESTEA in U.S. »

New Age Beverages (NBEV)…

NBEV

New Age Beverages

$3.07

0.335 (12.27%)

NSRGY

Nestle

$0.00

(0.00%)

KO

Coca-Cola

$53.49

-0.02 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Hot Stocks
Breaking Hot Stocks news story on TSMC »

TSMC sees FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Earnings
TSMC sees Q4 revenue $10.2B-$10.3B, consensus $9.63B »

Gross profit margin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HON

Honeywell

$163.86

0.2 (0.12%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Earnings
Honeywell reports Q3 adj. EPS $2.08, consensus $2.01 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:32
10/17/19
10/17
06:32
10/17/19
06:32
Earnings
TSMC reports Q3 EPS 62c, consensus 60c »

Reports Q3 revenue $9.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TXT

Textron

$50.52

-0.15 (-0.30%)

06:32
10/17/19
10/17
06:32
10/17/19
06:32
Earnings
Textron narrows FY19 EPS view to $3.70-$3.80 from $3.65-$3.85, consensus $3.74 »

The company revised its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

06:31
10/17/19
10/17
06:31
10/17/19
06:31
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SNA

Snap-On

$157.68

-0.64 (-0.40%)

06:31
10/17/19
10/17
06:31
10/17/19
06:31
Earnings
Snap-On reports Q3 EPS $2.96, consensus $2.94 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TXT

Textron

$50.52

-0.15 (-0.30%)

06:30
10/17/19
10/17
06:30
10/17/19
06:30
Earnings
Textron reports Q3 EPS 95c, consensus 85c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$142.04

-0.94 (-0.66%)

06:29
10/17/19
10/17
06:29
10/17/19
06:29
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MNST

Monster Beverage

$56.54

0.27 (0.48%)

06:28
10/17/19
10/17
06:28
10/17/19
06:28
Downgrade
Monster Beverage rating change  »

Monster Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$189.62

0.81 (0.43%)

, PYPL

PayPal

$103.11

-0.43 (-0.42%)

06:28
10/17/19
10/17
06:28
10/17/19
06:28
Periodicals
Facebook's Marcus says Libra 'absolutely not' in jeopardy, Yahoo Finance reports »

Facebook's (FB)…

FB

Facebook

$189.62

0.81 (0.43%)

PYPL

PayPal

$103.11

-0.43 (-0.42%)

EBAY

eBay

$38.91

0.03 (0.08%)

BKNG

Booking Holdings

$2,028.24

10.61 (0.53%)

V

Visa

$177.87

-0.93 (-0.52%)

MA

MasterCard

$278.40

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

06:27
10/17/19
10/17
06:27
10/17/19
06:27
Recommendations
Netflix analyst commentary  »

Netflix reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MAT

Mattel

$11.50

0.105 (0.92%)

, WMT

Walmart

$119.44

-0.08 (-0.07%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Periodicals
Walmart, Mattel 'lease floors' in KidHQ interactive store, WSJ reports »

Mattel (MAT) and Walmart…

MAT

Mattel

$11.50

0.105 (0.92%)

WMT

Walmart

$119.44

-0.08 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

CXP

Columbia Property

$20.31

0.05 (0.25%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Downgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:23
10/17/19
10/17
06:23
10/17/19
06:23
Earnings
Chart Industries sees FY20 adjusted EPS $4.75-$5.25, consensus $5.06 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

AAPL

Apple

$234.59

-0.67 (-0.28%)

06:22
10/17/19
10/17
06:22
10/17/19
06:22
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.